Leucine aminopeptidase 3:a promising serum biomarker candidate for nonalcoholic steatohepatitis diagnosis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110152 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Lina Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 71…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Key Science and Technology Program of Shaanxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND & AIMS: Nonalcoholic steatohepatitis (NASH) is a highly prevalent liver disease that lacks targeted therapeutic drugs and non-invasive diagnostic methods. Increasing evidence demonstrated that aberrant expression of leucine aminopeptidase 3 (LAP3) is involved in NASH. Herein, we aimed to investigate whether LAP3 can be a promising serum biomarker for NASH diagnosis. METHODS: Liver tissues and serum from NASH rats, serum from NASH patients, and liver biopsies from chronic hepatitis B (CHB) patients combined with NASH (CHB+NASH) were obtained to evaluate the LAP3 level. Correlation analysis was conducted to evaluate the association between LAP3 expression and clinical indexes in CHB patients and CHB+NASH patients. ROC curve analysis of LAP3 in the serum and liver was applied to assess whether LAP3 can be a promising biomarker for NASH diagnosis. RESULTS: LAP3 was significantly upregulated in serum and hepatocytes of NASH rats and patients with NASH. Correlation analysis revealed that LAP3 in the liver of CHB patients and CHB+NASH patients showed a strong positive correlation with lipidome indicators total cholesterol (TC) and triglyceride (TG), and liver fibrosis indicator hyaluronic acid (HA), which showed a negative correlation with the international normalized ratio of prothrombin coagulation (INR) and liver injury indicator aspartate aminotransferase (AST). For NASH, the diagnostic accuracy of ALT > LAP3 > AST, the sensitivity LAP3 (0.87) > ALT (0.5957) > AST (0.2941), the specificity AST (0.975) > ALT (0.9) > LAP3 (0.5). CONCLUSION: Our data urge that LAP3 can serve as a promising serum biomarker candidate for NASH diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China; Key Laboratory of Environment and Genes Related to Diseas…
- Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), 1068, Xueyuan Avenue, Shenzhen 518055, China.
- Department of Infectious Diseases, The Affiliated Hospital of Yan'an University Yan'an, China; Department of Infectious Diseases, Yan'an Second People's Hospital, Yan'an, China.
Förderung
- Key Science and Technology Program of Shaanxi Province
- National Natural Science Foundation of China
Zitieren
APA
Feng, L., Riaz, F., Lu, K., Cheng, X., Chen, Y., Zhao, R., Wu, L., Lu, S., & Li, D. (2023). Leucine aminopeptidase 3:a promising serum biomarker candidate for nonalcoholic steatohepatitis diagnosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110152
Vancouver
Feng L, Riaz F, Lu K, Cheng X, Chen Y, Zhao R, et al. Leucine aminopeptidase 3:a promising serum biomarker candidate for nonalcoholic steatohepatitis diagnosis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110152
BibTeX
@article{Feng2023,
author = {Feng, Lina and Riaz, Farooq and Lu, Kaikai and Cheng, Xiaona and Chen, Yanping and Zhao, Rong and Wu, Litao and Lu, Shemin and Li, Dongmin},
title = {Leucine aminopeptidase 3:a promising serum biomarker candidate for nonalcoholic steatohepatitis diagnosis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110152}
}
EUVIMED